Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
about
Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysisContribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.Bringing Transparency to Medicine: Exploring Physicians' Views and Experiences of the Sunshine Act.Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.President's Address: Physicians and the Pharmaceutical Industry.Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.Cross-sectional Analysis of the Relationship between Paranasal Sinus Balloon Catheter Dilations and Industry Payments among Otolaryngologists.Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest: Challenges and Solutions.Gynaecologists and industry: ain't no sunshine.Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.Powered by Sunshine: Next Steps for Making Transparency Matter.Industry support of physician education in the USA.The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study.Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review.Towards Patient-Centered Conflicts of Interest Policy.It's the Prices, Advanced Capitalism, and the Need for Rate Setting - Stupid.The Receipt of Industry Payments is Associated with Prescribing Promoted Alpha-Blockers and Overactive Bladder Medications.Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.Having Their Cake and Eating It Too: Physician Skepticism of the Open Payments Program.The Effects of the Sunshine Act: What Can and Should We Expect?Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.Conflicts of interest of editors of medical journals.Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts
P2860
Q29994595-E4E26733-A77B-4107-9336-5F9C9493EA50Q33815256-7EEB1ADD-B294-438D-AF25-6C31E5669D1DQ37185115-F9A403A2-9E0C-4CC3-B0AA-1E48E934617AQ38767427-F508DCE1-846D-4641-8E34-39385151A41FQ38796535-812AC563-7A5F-40F0-9077-2274757CF5F7Q38808074-0ED319A4-5B8B-4E86-B913-3EA5BB9EA8B7Q38808785-4AAFD181-378A-4AE6-B545-1970B874BA2EQ41112143-9D3FB811-AB53-447F-8565-E5A241AEB019Q42215595-73DF2947-59B1-409C-BA3D-364725443AD1Q42689858-27BE840C-09BA-4EE5-AC82-5B6658D71747Q42699082-7755C034-E9BA-4833-B629-AD7FBF228B7BQ47121834-744D812F-A94E-4148-BD0A-4548103ADD70Q47657946-10D8ADB1-DF4C-4258-B72A-004DD1952CADQ47738447-FFA3AE2F-41B4-4255-9E95-6F73519FDF4AQ47852975-48703BF2-641E-4C72-9AAF-E2C8FD886714Q47998668-FD8381BE-4C7C-44F1-9CCB-DD0BDCAE777DQ48107584-08B94120-CC86-490B-8079-AA07FD0F5B13Q48361892-5A847EA9-C4FA-4F06-9504-3F95E8C9C0B6Q49572096-536E8A06-C6DA-40CE-AD37-298D3EA19BC3Q50133431-CEA166B1-9715-4260-85EB-21989C99C88FQ50219873-E527EC27-9205-4752-87BF-89DB5E12FF61Q51812869-B49F11CA-D43C-4137-94BD-0753FB605D6CQ52572355-279CEC26-8CB3-49AF-8646-583410722248Q52612467-732A1DF7-7E7A-442F-8F16-E074F67748E7Q53271775-6C2474E0-373E-47C1-9107-0105858D0725Q54683040-8600512D-C21D-43E5-8489-3F6142ECE080Q55342152-BD3988AA-A327-45C3-AA65-9F2F5CEDDDD4Q55363483-BCA2A718-7028-4D73-A8C7-530D0E4A494EQ57806288-8A9F708E-6E32-4C44-BF49-8ADFCDF880EE
P2860
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Association of Industry Paymen ...... name Statins in Massachusetts.
@en
Association of Industry Paymen ...... name Statins in Massachusetts.
@nl
type
label
Association of Industry Paymen ...... name Statins in Massachusetts.
@en
Association of Industry Paymen ...... name Statins in Massachusetts.
@nl
prefLabel
Association of Industry Paymen ...... name Statins in Massachusetts.
@en
Association of Industry Paymen ...... name Statins in Massachusetts.
@nl
P2093
P1476
Association of Industry Paymen ...... -name Statins in Massachusetts
@en
P2093
Jerry Avorn
Jessica M Franklin
Joan Landon
P304
P356
10.1001/JAMAINTERNMED.2016.1709
P577
2016-06-01T00:00:00Z